Suppliers / Xuzhou Wanbang Jinqiao Pharma

Xuzhou Wanbang Jinqiao Pharma

China Updated 9 July 2026

Xuzhou Wanbang Jinqiao Pharma is an API manufacturer based in China. It holds 5 active US drug master files across a filed portfolio of 5 molecules.

5
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
China, China 3038199656

What they file, and where

Molecule Regulators Docs
Azilsartan Medoxomil US FDA 1
Deucravacitinib US FDA 1
Mavacamten US FDA 1
Venetoclax US FDA 1
Zavegepant US FDA 1

Also appears on these molecule pages

Azilsartan Medoxomil API Deucravacitinib API Mavacamten API Venetoclax API Zavegepant API

Comparing suppliers?

Choose your molecules and target markets. Xuzhou Wanbang Jinqiao Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability